New patent expiration for Teva Branded drug SEASONIQUE
Annual Drug Patent Expirations for SEASONIQUE Seasonique is a drug marketed by Teva Branded Pharm and is included in one […]
New patent expiration for Teva Branded drug SEASONIQUE Read Post »
Annual Drug Patent Expirations for SEASONIQUE Seasonique is a drug marketed by Teva Branded Pharm and is included in one […]
New patent expiration for Teva Branded drug SEASONIQUE Read Post »
Annual Drug Patent Expirations for DYMISTA Dymista is a drug marketed by Mylan Speciality Lp and is included in one
New patent expiration for Mylan Speciality drug DYMISTA Read Post »
Annual Drug Patent Expirations for FYCOMPA Fycompa is a drug marketed by Eisai Inc and is included in two NDAs.
New patent expiration for Eisai Inc drug FYCOMPA Read Post »
FYCOMPA (perampanel) Eisai inc Patent: 6,949,571 Expiration: Jun 8, 2023 See More … For more information on how DrugPatentWatch can
Drug Patent Expirations for the Week of June 4, 2023 Read Post »
Annual Drug Patent Expirations for NUZYRA Nuzyra is a drug marketed by Paratek Pharms Inc and is included in two
New patent expiration for Paratek Pharms drug NUZYRA Read Post »
NUZYRA (omadacycline tosylate) Paratek pharms inc Patent: 7,553,828 Expiration: Jun 2, 2023 See More … For more information on how
Drug Patent Expirations for the Week of May 28, 2023 Read Post »
Annual Drug Patent Expirations for SELZENTRY Selzentry is a drug marketed by Viiv Hlthcare and is included in two NDAs.
New patent expiration for Viiv Hlthcare drug SELZENTRY Read Post »
Annual Drug Patent Expirations for MYDAYIS Mydayis is a drug marketed by Takeda Pharms Usa and is included in one
New patent expiration for Takeda Pharms drug MYDAYIS Read Post »
SELZENTRY (maraviroc) Viiv hlthcare Patent: 7,368,460 Expiration: May 25, 2023 See More … For more information on how DrugPatentWatch can
Drug Patent Expirations for the Week of May 21, 2023 Read Post »
Get fresh news and insights, drug patent expirations & more…